How asymptomatic is asymptomatic primary hyperparathyroidism?

Experimental and Clinical Endocrinology and Diabetes

Volumn 108, Issue 4, 2000, Pages 265-274

  Hasse, C ^a   Sitter, H ^a   Bachmann, S ^b   Zielke, A ^a   Koller, M ^a   Nies, C ^a   Lorenz, W ^a   Rothmund, M ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Stadtkrankenhaus Korbach ^*  (Germany)

Author keywords

Asymptomatic; Primary hyperparathyroidism; Signs and symptoms; Surgical outcome

Indexed keywords

CALCIUM;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PARATHYROIDECTOMY; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PREDICTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; STANDARDIZATION; SURGICAL MORTALITY; SYMPTOM;

CALCIUM; COHORT STUDIES; EPIDEMIOLOGIC METHODS; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM; MULTIVARIATE ANALYSIS; PARATHYROIDECTOMY;

EID: 0033925274     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7754     Document Type: Article

References (39)

1. Anonymous: Consensus development conference statement. J Bone Mineral Res 6: 9-13, 1991
2. Auerbach GA, Marx SJ, Spiegel AM: Parathyroid hormone, calcitonin and the calciferols. In: Wilson JD, Foster DW (eds) Williams textbook of endocrinology, vol 8, pp 1431-1432. Saunders, Philadelphia, London, Toronto, 1991
3. Bilezikian JP, Silverberg SJ, Shane E, Parisien M, Dempster DW: Characterization and evaluation of asymptomatic primary hyperparathyroidism. J Bone Mineral Res 6: 85-124, 1991
4. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L: Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305: 160-164, 1992
5. Breetvelt IS, van Dam FSAM: Underreporting by cancer patients: The case of response-shift. Soc Sci Med 32: 981-987, 1991
6. Burney RE, Jones KR, Christy B, Thompson NW: Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 125: 608-614, 1999
7. Burney RE, Jones KR, Coon JW, Blewitt DK, Herm AM: Assessment of patient outcomes after operation for primary hyperparathyroidism. Surgery 120: 1013-1019, 1996
8. Chan AK, Duh OY, Katz MH, Siperstein AE, Clark OH: Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. Ann Surg 222: 402-413, 1995
9. Chou F-F, Sheen-Chen S-M, Leong C-P: Neuromuscular recovery after parathyreoidectomy in primary hyperparathyroidism. Surgery 117: 18-25, 1995
10. Christensson T, Hellstrom K, Wengle B, Alveryd A, Wikland B: Prevalence of hypercalcaemia in a health screening in Stockholm. Acta Med Scand 200: 131-137, 1976
11. Clark OH, Wilkes W, Siperstein AE, Duh QY: Diagnosis and management of asymptomatic hyperparathyroidism: Safety, efficacy, and deficiencies in our knowledge. J Bone Mineral Res 6: 135-142 and 151-152, 1991
12. Clark OH: Presidential address: "Asymptomatic" primary hyperparathyroidism: Is parathyroidectomy indicated? Surgery 116: 947-953, 1994
13. Fitzpatrick LA, Bilezikian JP: Primary hyperparathyroidism. In: Becker KL (ed) Principles and practice of endocrinology and metabolism, vol 1, pp 431-433. Lippincott, Grand Rapids, New York, St. Louis, San Francisco, London, Sydney, Tokyo, 1990
14. Habener J, Arnold A, Potts JT: Hyperparathyroidism. In: DeGroot LJ (ed) Endocrinology, vol 2, pp 1048-1055. Saunders, Philadelphia, London, Toronto, 1995
15. Harrison BJ, Wheeler MH: Asymptomatic primary hyperparathyroidism. World J Surg 15: 724-729, 1991
16. Heath H, Hodgson SF, Kennedy MA: Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. New Engl J Med 302: 189-193, 1980
17. Heath H: III. Clinical spectrum of primary hyperparathyroidism: Evolution with changes in medical practice and technology. J Bone Mineral Res 6: 63-70, 1991
18. Hedbäck G, Oden A, Tisell L-E: The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 15: 399-407, 1991
19. Hedbäck G, Tisell L-E, Bengtsson B-A, Hedman I, Oden A: Premature death in patients operated on for primary hyperparathyroidism. World J Surg 14: 829-836, 1990
20. Joborn C, Hetta J, Lind L, Rastad J, Akerström G, Ljunghall S: Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery 105: 72-78, 1989
21. Kaplan EL, Yashiro T, Salti G: Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease. Ann Surg 215: 300-317, 1992
22. Kjellman M, Sandelin K, Farnebo LO: Primary hyperparathyroidism. Low surgical morbidity supports liberal attitude to operation. Arch Surg 129: 237-240, 1994
23. Lundgren E, Reastad J, Ridefelt P, Juhlin C, Akerström G, Ljunghall S: Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism. Surgery 112: 1123-1129, 1992
24. Melliere S, Berrahal D, Perlemuter L, Hindie E, Simon D: Primary hyperparathyroidism. Relationships of symptoms to age, sex, calcemia, anatomical lesions and weight of glands. Presse Med 24: 1889-1893, 1995
25. Melton LJ: Epidemiology of primary hyperparathyroidism. J Bone Mineral Res 6: 25-32, 1991
26. Palmer M, Bergstrom R, Akerström G, Adami H-O, Jakobsson S, Ljunghall S: Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 jears of follow-up. Lancet 10: 59-62, 1987
27. Palmer M, Jakobsson S, Akerstrom G, Ljunghall S: Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest 18: 39-46, 1988
28. Parfitt AM, Rao DS, Kleerekoper M: Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and consideration bearing on the need for surgical intervention. J Bone Mineral Res 6: 97-124, 1991
29. Pasieka JL, Parsons LL: Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22: 513-519, 1998
30. Pennebaker J: The psychology of physical symptoms, vol 5, pp 1-197. Springer, New York, 1982
31. Ronni-Sivula H: Cause of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 74: 13-18, 1985
32. Silverberg SJ, Bilezikian JP, Bone HG, Talpos GB, Horwitz MJ, Stewart AF: Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol & Metab 84: 2275-2285, 1999
33. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, Bilezikian JP: Longitudinal measurement of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 80: 723-728, 1995
34. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP: A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341: 1249-1255, 1999
35. Sivula A, Pelkonen R: Long term health risk of primary hyperparathyroidism: the effect of surgery. Ann Med 28: 95-100, 1996
36. Solomon BL, Schaaf M, Smallridge RC: Psychologic symptoms before and after parathyroid surgery. Am J Med 96: 101-107, 1994
37. Sosa JA, Powe NR, Levine MA, Udelsman R, Zeiger MA: Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons. J Clin Endocrinol Metab 83: 2658-2665, 1998
38. Uden P, Chan AK, Duh QY, Siperstein AE, Clark OH: Primary hyperparathyroidism in younger and older patients: Clinical symptoms and outcome of surgery. World J Surg 16: 791-797, 1992
39. Ware JJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30: 473-483, 1992